Investment analysts at Cantor Fitzgerald increased their FY2025 earnings estimates for Gossamer Bio in a report issued on Monday, March 24th. Cantor Fitzgerald analyst O. Brayer now expects that the ...

Now, findings of a recent multicenter study led by Mariella Filbin, MD, PhD, co-director of the Brain Tumor Center at Boston Children’s Hospital and Dana-Farber Cancer Institute, suggest that PDGFRA ...

Investment analysts at HC Wainwright lowered their FY2028 earnings estimates for Gossamer Bio in a research note issued on ...

A new therapy offers hope for treating pediatric brain tumors, targeting cancer cells while minimizing side effects for young ...

The inhibition of tyrosine kinases blocks the activation of VEGF receptor and platelet-derived growth factor receptor, thereby reducing angiogenesis and vascular leakage. Unlike current anti-VEGF ...

High-grade glioma, a difficult-to-treat and aggressive form of pediatric and adult brain cancer, responded to FDA-approved avapritinib. | Drug Discovery And Development ...

KIT and platelet-derived growth factor receptor (PDGFR), which lead to imatinib resistance and the equivalent EGFR T790M mutation, which causes resistance to erlotinib and geftinib 5. Therapeutic ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.